Digital Therapeutics
A new category of medicine
This is our belief to develop digital therapeutics
Digital therapeutics is SaMD(Software as a Medical Device) that employs high quality software to treat patients
A leading Innovative Technology
Suitable for mobile environment
Continuous treatment and patient monitoring with simultaneous mass distributions are all possible regardless of location and time unlike conventional therapies
Effective adjuvant therapy
Maximize the effectiveness of treatment along with existing therapies and further provide an opportunity to go beyond the traditional options
Personalized treatment based on big data
Offer prescribed digital therapeutics and diagnostic programs driven by AI algorithm
Core Competencies
Analysis
Our analysts differentiate development strategy by focusing on medical unmet needs
R & D
Our physicians and scientists research and develop evidence-based solutions
SW Development
Our team develops captivating programs in compliance with industry regulations and standards
Clinical Validation
Our priority is to prove its efficacy and safety in collaboration with top notch institutions
BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States
Product Pipeline
Copyright 2021 - BIXINK │ Terms of Use │ Contact │ Privacy
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea
